Continuous assessment of clinical course, outcome and resources in patients treated for Post-COVID
Recruiting
- Conditions
- U09.9U07.9Post COVID-19 condition, unspecified
- Registration Number
- DRKS00030974
- Lead Sponsor
- MU Klinikum der Universität München
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
(1) Patients with COVID-19 sequelae lasting at least 4 weeks with documented SARS-CoV-2 infection within the past 48 months.
(2) Persons who were treated for acute infections other than COVID-19 or who had COVID-19 within the past 48 month without ongoing signs and symptoms of COVID-19 as control group.
(3) All participants need to be of full age.
Exclusion Criteria
(1) Patients presenting in the complete recovery phase of PCS at inclusion or (2) obvious alternative explanations for the PCS-associated signs and symptoms or
(3) onset of PCS-associated signs and symptoms before acute COVID-19.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method (1) Quality of life as measured by validated and standardized assessment tools (WHOQOL-BREF, PROMIS-10)<br>(2) PCS-associated deterioration (e.g. need for hospitalization, increase in medical interventions or medical visits)<br>(3) resolution of post-COVID-syndrome
- Secondary Outcome Measures
Name Time Method (1) Overall survival<br>(2) Occurence of life-threatening complications<br>(3) Time to deterioration